Background: Height and body mass index (BMI) are associated with higher ovarian cancer risk in the general population, but whether such associations exist among BRCA1/2 mutation carriers is unknown. Methods: We applied a Mendelian randomisation approach to examine height/BMI with ovarian cancer risk using the Consortium of Investigators for the Modifiers of BRCA1/2 (CIMBA) data set, comprising 14,676 BRCA1 and 7912 BRCA2 mutation carriers, with 2923 ovarian cancer cases. We created a height genetic score (height-GS) using 586 height-associated variants and a BMI genetic score (BMI-GS) using 93 BMI-associated variants. Associations were assessed using weighted Cox models. Results: Observed height was not associated with ovarian cancer risk (hazard ratio [HR]: 1.07 per 10-cm increase in height, 95% confidence interval [CI]: 0.94–1.23). Height-GS showed similar results (HR = 1.02, 95% CI: 0.85–1.23). Higher BMI was significantly associated with increased risk in premenopausal women with HR = 1.25 (95% CI: 1.06–1.48) and HR = 1.59 (95% CI: 1.08–2.33) per 5-kg/m2 increase in observed and genetically determined BMI, respectively. No association was found for postmenopausal women. Interaction between menopausal status and BMI was significant (Pinteraction < 0.05). Conclusion: Our observation of a positive association between BMI and ovarian cancer risk in premenopausal BRCA1/2 mutation carriers is consistent with findings in the general population.

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers / Qian, F.; Rookus, M. A.; Leslie, G.; Risch, H. A.; Greene, M. H.; Aalfs, C. M.; Adank, M. A.; Adlard, J.; Agnarsson, B. A.; Ahmed, M.; Aittomaki, K.; Andrulis, I. L.; Arnold, N.; Arun, B. K.; Ausems, M. G. E. M.; Azzollini, J.; Barrowdale, D.; Barwell, J.; Benitez, J.; Bialkowska, K.; Bonadona, V.; Borde, J.; Borg, A.; Bradbury, A. R.; Brunet, J.; Buys, S. S.; Caldes, T.; Caligo, M. A.; Campbell, I.; Carter, J.; Chiquette, J.; Chung, W. K.; Claes, K. B. M.; Collee, J. M.; Collonge-Rame, M. -A.; Couch, F. J.; Daly, M. B.; Delnatte, C.; Diez, O.; Domchek, S. M.; Dorfling, C. M.; Eason, J.; Easton, D. F.; Eeles, R.; Engel, C.; Evans, D. G.; Faivre, L.; Feliubadalo, L.; Foretova, L.; Friedman, E.; Frost, D.; Ganz, P. A.; Garber, J.; Garcia-Barberan, V.; Gehrig, A.; Glendon, G.; Godwin, A. K.; Gomez Garcia, E. B.; Hamann, U.; Hauke, J.; Hopper, J. L.; Hulick, P. J.; Imyanitov, E. N.; Isaacs, C.; Izatt, L.; Jakubowska, A.; Janavicius, R.; John, E. M.; Karlan, B. Y.; Kets, C. M.; Laitman, Y.; Lazaro, C.; Leroux, D.; Lester, J.; Lesueur, F.; Loud, J. T.; Lubinski, J.; Lukomska, A.; Mcguffog, L.; Mebirouk, N.; Meijers-Heijboer, H. E. J.; Meindl, A.; Miller, A.; Montagna, M.; Mooij, T. M.; Mouret-Fourme, E.; Nathanson, K. L.; Nehoray, B.; Neuhausen, S. L.; Nevanlinna, H.; Nielsen, F. C.; Offit, K.; Olah, E.; Ong, K. -R.; Oosterwijk, J. C.; Ottini, L.; Parsons, M. T.; Peterlongo, P.; Pfeiler, G.; Pradhan, N.; Radice, P.; Ramus, S. J.; Rantala, J.; Rennert, G.; Robson, M.; Rodriguez, G. C.; Salani, R.; Scheuner, M. T.; Schmutzler, R. K.; Shah, P. D.; Side, L. E.; Simard, J.; Singer, C. F.; Steinemann, D.; Stoppa-Lyonnet, D.; Tan, Y. Y.; Teixeira, M. R.; Terry, M. B.; Thomassen, M.; Tischkowitz, M.; Tognazzo, S.; Toland, A. E.; Tung, N.; van Asperen, C. J.; van Engelen, K.; van Rensburg, E. J.; Venat-Bouvet, L.; Vierstraete, J.; Wagner, G.; Walker, L.; Weitzel, J. N.; Yannoukakos, D.; Antoniou, A. C.; Goldgar, D. E.; Olopade, O. I.; Chenevix-Trench, G.; Rebbeck, T. R.; Huo, D.; on behalf of, Cimba. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - 121:2(2019), pp. 180-192. [10.1038/s41416-019-0492-8]

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

Brunet J.;Miller A.;Ottini L.;
2019

Abstract

Background: Height and body mass index (BMI) are associated with higher ovarian cancer risk in the general population, but whether such associations exist among BRCA1/2 mutation carriers is unknown. Methods: We applied a Mendelian randomisation approach to examine height/BMI with ovarian cancer risk using the Consortium of Investigators for the Modifiers of BRCA1/2 (CIMBA) data set, comprising 14,676 BRCA1 and 7912 BRCA2 mutation carriers, with 2923 ovarian cancer cases. We created a height genetic score (height-GS) using 586 height-associated variants and a BMI genetic score (BMI-GS) using 93 BMI-associated variants. Associations were assessed using weighted Cox models. Results: Observed height was not associated with ovarian cancer risk (hazard ratio [HR]: 1.07 per 10-cm increase in height, 95% confidence interval [CI]: 0.94–1.23). Height-GS showed similar results (HR = 1.02, 95% CI: 0.85–1.23). Higher BMI was significantly associated with increased risk in premenopausal women with HR = 1.25 (95% CI: 1.06–1.48) and HR = 1.59 (95% CI: 1.08–2.33) per 5-kg/m2 increase in observed and genetically determined BMI, respectively. No association was found for postmenopausal women. Interaction between menopausal status and BMI was significant (Pinteraction < 0.05). Conclusion: Our observation of a positive association between BMI and ovarian cancer risk in premenopausal BRCA1/2 mutation carriers is consistent with findings in the general population.
Adult; Aged; Female; Humans; Menopause; Middle Aged; Ovarian Neoplasms; Proportional Hazards Models; Body Height; Body Mass Index; Genes, BRCA1; Genes, BRCA2; Heterozygote; Mendelian Randomization Analysis; Mutation
01 Pubblicazione su rivista::01a Articolo in rivista
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers / Qian, F.; Rookus, M. A.; Leslie, G.; Risch, H. A.; Greene, M. H.; Aalfs, C. M.; Adank, M. A.; Adlard, J.; Agnarsson, B. A.; Ahmed, M.; Aittomaki, K.; Andrulis, I. L.; Arnold, N.; Arun, B. K.; Ausems, M. G. E. M.; Azzollini, J.; Barrowdale, D.; Barwell, J.; Benitez, J.; Bialkowska, K.; Bonadona, V.; Borde, J.; Borg, A.; Bradbury, A. R.; Brunet, J.; Buys, S. S.; Caldes, T.; Caligo, M. A.; Campbell, I.; Carter, J.; Chiquette, J.; Chung, W. K.; Claes, K. B. M.; Collee, J. M.; Collonge-Rame, M. -A.; Couch, F. J.; Daly, M. B.; Delnatte, C.; Diez, O.; Domchek, S. M.; Dorfling, C. M.; Eason, J.; Easton, D. F.; Eeles, R.; Engel, C.; Evans, D. G.; Faivre, L.; Feliubadalo, L.; Foretova, L.; Friedman, E.; Frost, D.; Ganz, P. A.; Garber, J.; Garcia-Barberan, V.; Gehrig, A.; Glendon, G.; Godwin, A. K.; Gomez Garcia, E. B.; Hamann, U.; Hauke, J.; Hopper, J. L.; Hulick, P. J.; Imyanitov, E. N.; Isaacs, C.; Izatt, L.; Jakubowska, A.; Janavicius, R.; John, E. M.; Karlan, B. Y.; Kets, C. M.; Laitman, Y.; Lazaro, C.; Leroux, D.; Lester, J.; Lesueur, F.; Loud, J. T.; Lubinski, J.; Lukomska, A.; Mcguffog, L.; Mebirouk, N.; Meijers-Heijboer, H. E. J.; Meindl, A.; Miller, A.; Montagna, M.; Mooij, T. M.; Mouret-Fourme, E.; Nathanson, K. L.; Nehoray, B.; Neuhausen, S. L.; Nevanlinna, H.; Nielsen, F. C.; Offit, K.; Olah, E.; Ong, K. -R.; Oosterwijk, J. C.; Ottini, L.; Parsons, M. T.; Peterlongo, P.; Pfeiler, G.; Pradhan, N.; Radice, P.; Ramus, S. J.; Rantala, J.; Rennert, G.; Robson, M.; Rodriguez, G. C.; Salani, R.; Scheuner, M. T.; Schmutzler, R. K.; Shah, P. D.; Side, L. E.; Simard, J.; Singer, C. F.; Steinemann, D.; Stoppa-Lyonnet, D.; Tan, Y. Y.; Teixeira, M. R.; Terry, M. B.; Thomassen, M.; Tischkowitz, M.; Tognazzo, S.; Toland, A. E.; Tung, N.; van Asperen, C. J.; van Engelen, K.; van Rensburg, E. J.; Venat-Bouvet, L.; Vierstraete, J.; Wagner, G.; Walker, L.; Weitzel, J. N.; Yannoukakos, D.; Antoniou, A. C.; Goldgar, D. E.; Olopade, O. I.; Chenevix-Trench, G.; Rebbeck, T. R.; Huo, D.; on behalf of, Cimba. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - 121:2(2019), pp. 180-192. [10.1038/s41416-019-0492-8]
File allegati a questo prodotto
File Dimensione Formato  
Qian_Mendelian-randomisation_2019.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 448.59 kB
Formato Adobe PDF
448.59 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1415477
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 16
social impact